Sebaldt R J, Nattel S, Kreeft J H, Ogilvie R I
Ann Intern Med. 1984 Nov;101(5):632-4. doi: 10.7326/0003-4819-101-5-632.
A novel technique to achieve rapidly and continually maintain therapeutic lidocaine concentrations was designed according to known pharmacokinetic properties of the drug and was tested in 12 patients who required immediate lidocaine prophylaxis because of suspected acute myocardial infarction. The serum lidocaine concentrations achieved by this method remained within the therapeutic range (1.2 to 5.0 mg/L) in 83 of 84 determinations and showed little fluctuation over time for individual patients. Unlike previously recommended dose regimens for lidocaine, this technique uses an exponentially declining infusion and has the advantages of greater simplicity, less chance of medication error, and avoidance of rapid changes of lidocaine concentrations. Furthermore, similar methods can be applied when rapid attainment of stable plasma drug concentrations is needed for clinical or experimental pharmacologic studies.
根据利多卡因已知的药代动力学特性,设计了一种能快速并持续维持治疗性利多卡因浓度的新技术,并在12例因疑似急性心肌梗死而需要立即进行利多卡因预防的患者中进行了测试。通过该方法测得的血清利多卡因浓度在84次测定中有83次保持在治疗范围内(1.2至5.0毫克/升),且个体患者的浓度随时间波动很小。与先前推荐的利多卡因给药方案不同,该技术采用指数递减输注,具有更简单、用药错误几率更小以及避免利多卡因浓度快速变化的优点。此外,当临床或实验药理学研究需要快速达到稳定的血浆药物浓度时,也可应用类似方法。